0% found this document useful (0 votes)
36 views1 page

4 6027044348535767490 PDF

Download as pdf or txt
Download as pdf or txt
Download as pdf or txt
You are on page 1/ 1

COVID19 –

Prelim data from case reports and case studies from different resources – Lancet/BMJ,
NEMJ, Infection disease journal
Mukhmohit singh
Sensitive test -RTPCR –
Diagnosis by RT-PCR (FDA approved kits)
CT chest is very good indicator for clinical status of patient

severe cases - often associated with NAGMA, ARDS

Treatment – multiple RCTs are on..


• Remdesivir – new drug, promising result, toxicity and safety not established
• Lpv/R – established drug profile, shows good results, but larger cohort is required to
draw conclusive evidence
• Lpv/R/Ribavarin – triple drug –
o reasonable anti corona virus effects
o positive outcomes in animal models for MERS/CoV
o small human cohorts (< 40-50 patients) have been tested, results awaited
o dosing, toxicity not yet established
• chloroquine and hydroxychloroquine
o shown to have innate antiviral action – to what extent – unknown?
o small cohort, quasi trials are done..(I am working on data, non-conclusive
results as of now)
o maybe associated cardiac effects, porphyria, haematological disorders maybe
of concern
• Oseltamivir – our life savour drug in Swine Flu pandemic – is against the H and N
(anti – influenza) .. still to be researched – but I personally do not have any positive
results from the data compiled and pre-liminary analysis)

what proves best:


- Oxygen therapy (helmet > nasal)
- Non-invasive ventilation (CPAP better results than BiPAP – positive results from
larger cohort)
- empiric anti-bacterial to avoid secondary infections

in severe cases of cytokine storm:


- steroids and immunosuppressive
- Tocilizumab – mAb – maybe of some benefit in case of known and established
cytokine storm in severe COVID19 infection cases. case series have been reported
with low evidence
-
Note: Steroid is usually ‘not’ indicated. they may promote viral shedding in early course of
the disease.

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy